Login / Signup
The impact of direct-acting antiviral therapy for hepatitis C on hepatocellular carcinoma risk.
Feng Su
George N Ioannou
Published in:
Current hepatology reports (2018)
Recent studies provide evidence that DAA-induced SVR reduces HCC risk.
Keyphrases
</>
breast cancer risk